EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alterations in the expression of homologous recombination repair (HRR) genes in breast cancer tissues considering germline BRCA1/2 mutation status

Izabela Laczmanska, Rafal Matkowski, Stanislaw Supplitt, Pawel Karpinski, Mariola Abrahamowska, Lukasz Laczmanski, Adam Maciejczyk, Ewelina Czykalko, Ewelina Iwaneczko, Piotr Kasprzak, Bartłomiej Szynglarewicz, Maria Sasiadek

Breast Cancer Research and Treatment · 2024

DOI: 10.1007/s10549-024-07441-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2024. Verfasst von Izabela Laczmanska und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Faculty of Medicine, Wroclaw Medical University, Marcinkowskiego 1, 50-368, Wroclaw, Poland. Hauptthemen laut MEDLINE: Germ-Line Mutation, Breast Neoplasms, BRCA2 Protein, BRCA1 Protein. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstwo Zdrowia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Homologous recombination (HR) is a crucial DNA-repair mechanism, and its disruption can lead to the accumulation of mutations that initiate and promote cancer formation. The key HR genes, BRCA1 and BRCA2 , are particularly significant as their germline pathogenic variants are associated with a hereditary predisposition to breast and/or ovarian cancer. Materials and methods The study was performed on 45 FFPE breast cancer tissues obtained from 24 and 21 patients, with and without the germline BRCA1/2 mutation, respectively. The expression of 11 genes: BRCA1, BRCA2, ATM, BARD1, FANCA, FANCB, FANCI, RAD50, RAD51D, BRIP1, and CHEK2 was assessed using Custom RT2 PCR Array (Qiagen), and results were analysed using R.

Results

Cancer tissues from patients with BRCA1 or BRCA2 germline mutations displayed no significant differences in the expression of the selected HR genes compared to BRCA1 or BRCA2 wild-type cancer tissues. In BRCA1 mut cancer tissues, BRCA1 expression was significantly higher than in BRCA2 mut and BRCA wild-type cancer tissues.

Conclusions

In cancer tissues harbouring either BRCA1 or BRCA2 germline mutations, no significant differences in expression were observed at the mRNA level of any tested HR genes, except BRCA1 . However, the significant differences observed in BRCA1 expression between germline BRCA1 mut , germline BRCA2 mut and BRCA1/2 wt tissues may indicate a compensatory mechanism at the mRNA level to mitigate the loss of BRCA1 function in the cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Germ-Line MutationBreast NeoplasmsBRCA2 ProteinBRCA1 ProteinRecombinational DNA RepairHumansFemaleMiddle AgedAdultGene Expression Regulation, NeoplasticAgedGenetic Predisposition to Disease

Stichwörter der Autor:innen

BRCA1/2 deficiencyBreast cancerHomologous recombination (HR)Real-time PCR

Substanzen

BRCA2 ProteinBRCA1 ProteinBRCA1 protein, humanBRCA2 protein, human

Autor:innen und Institutionen

  • Department of Genetics, Faculty of Medicine, Wroclaw Medical University, Marcinkowskiego 1, 50-368, Wroclaw, Poland.
  • Lower Silesian Oncology, Pulmonology and Hematology Center, Hirszfeld Sq. 12, 53-413, Wroclaw, Poland.
  • Lower Silesian Oncology, Pulmonology and Hematology Center, Hirszfeld Sq. 12, 53-413, Wroclaw, Poland. rafal.matkowski@umw.edu.pl.
  • Department of Oncology, Faculty of Medicine, Wroclaw Medical University, Hirszfeld Sq. 12, 53-413, Wroclaw, Poland. rafal.matkowski@umw.edu.pl.
  • Department of Oncology, Faculty of Medicine, Wroclaw Medical University, Hirszfeld Sq. 12, 53-413, Wroclaw, Poland.
  • Laboratory of Genomics and Bioinformatics, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, 53-114, Wroclaw, Poland.

Förderung

  • Ministerstwo Zdrowia

Zitieren

APA

Laczmanska, I., Matkowski, R., Supplitt, S., Karpinski, P., Abrahamowska, M., Laczmanski, L., Maciejczyk, A., Czykalko, E., Iwaneczko, E., Kasprzak, P., Szynglarewicz, B., & Sasiadek, M. (2024). Alterations in the expression of homologous recombination repair (HRR) genes in breast cancer tissues considering germline BRCA1/2 mutation status. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07441-4

Vancouver

Laczmanska I, Matkowski R, Supplitt S, Karpinski P, Abrahamowska M, Laczmanski L, et al. Alterations in the expression of homologous recombination repair (HRR) genes in breast cancer tissues considering germline BRCA1/2 mutation status. Breast Cancer Research and Treatment. 2024. doi:10.1007/s10549-024-07441-4

BibTeX
@article{Laczmanska2024,
  author = {Laczmanska, Izabela and Matkowski, Rafal and Supplitt, Stanislaw and Karpinski, Pawel and Abrahamowska, Mariola and Laczmanski, Lukasz and Maciejczyk, Adam and Czykalko, Ewelina and Iwaneczko, Ewelina and Kasprzak, Piotr and Szynglarewicz, Bartłomiej and Sasiadek, Maria},
  title = {Alterations in the expression of homologous recombination repair (HRR) genes in breast cancer tissues considering germline BRCA1/2 mutation status},
  journal = {Breast Cancer Research and Treatment},
  year = {2024},
  doi = {10.1007/s10549-024-07441-4}
}
Kostenlos starten →